KRTX - Karuna Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $365.49. This is a potential upside of $35.66 (10.81%) from yesterday's end of day stock price of $329.83.

Karuna Therapeutics's activity chart (see below) currently has 136 price targets and 83 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 92.85% with an average time for these price targets to be met of 209.87 days.

Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 20-Feb-2024. First documented stock forecast 22-Jul-2019.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$330

$0.17 (0.05%)

$330

1 years 7 months 17 days ago
(20-Feb-2024)

2/4 (50%)

$11.41 (3.58%)

86

Hold

$245

$-84.83 (-25.72%)

$245

1 years 8 months 12 days ago
(25-Jan-2024)

12/13 (92.31%)

$-69 (-21.97%)

168

Buy

$295

$-34.83 (-10.56%)

$280

1 years 9 months 15 days ago
(22-Dec-2023)

2/3 (66.67%)

$-22.85 (-7.19%)

148

Hold

$227

$-102.83 (-31.18%)

$280

1 years 9 months 16 days ago
(21-Dec-2023)

4/5 (80%)

$-90.85 (-28.58%)

219

Buy

$330

$0.17 (0.05%)

$175

1 years 9 months 16 days ago
(21-Dec-2023)

4/5 (80%)

$12.15 (3.82%)

290

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KRTX (Karuna Therapeutics) average time for price targets to be met?

On average it took 209.87 days on average for the stock forecasts to be realized with a an average price target met ratio 92.85

Which analyst has the current highest performing score on KRTX (Karuna Therapeutics) with a proven track record?

JEFFREY HUNG

Which analyst has the most public recommendations on KRTX (Karuna Therapeutics)?

Jeffrey Hung works at MORGAN STANLEY and has 6 price targets and 7 ratings on KRTX

Which analyst is the currently most bullish on KRTX (Karuna Therapeutics)?

Charles Duncan with highest potential upside - $0.17

Which analyst is the currently most reserved on KRTX (Karuna Therapeutics)?

Liana Moussatos with lowest potential downside - -$195.83

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?